FDA Approves Yuflyma
FDA Approves Yuflyma (adalimumab-aaty), a Biosimilar to Humira JERSEY CITY, N.J.–(BUSINESS WIRE) May 24, 2023 –Celltrion USA today announced that the U.S. Food and Drug […]
Read moreHome »
KHN’s ‘What the Health?’: Wrapping Up Summer’s Health News
Can’t see the audio player? Click here to listen on Acast. You can also listen on Spotify, Apple Podcasts, Stitcher, Pocket Casts, or wherever you […]
Read more‘Free’ Screening? Know Your Rights to Get No-Cost Care
An ounce of prevention … well, you know the rest. In medicine, prevention aims to spot problems before they worsen, affecting both a patient’s health […]
Read moreDespite Losing Federal Money, California Is Still Testing Uninsured Residents for Covid — For Now
SACRAMENTO, Calif. — California is still offering free covid testing to uninsured residents even though the federal government ran out of money to pay for […]
Read moreCalifornia Handed Its Medicaid Drug Program to One Company. Then Came a Corporate Takeover.
SACRAMENTO, Calif. — Prescription drug costs for California’s massive Medicaid program were draining the state budget, so in 2019 Gov. Gavin Newsom asked the private […]
Read morePfizer CEO Pushes Yearly Shots for Covid. Not So Fast, Experts Say.
When Pfizer CEO Albert Bourla said March 13 that all Americans would need a second booster shot, it struck many covid experts as a self-serving […]
Read moreAs Omicron Surges, Effort to Vaccinate Young Children Stalls
Two months after Pfizer’s covid vaccine was authorized for children ages 5 to 11, just 27% have received at least one shot, according to Jan. […]
Read moreKHN’s ‘What the Health?’: Dems Agree to Agree, But Not on What to Agree On
Can’t see the audio player? Click here to listen on Acast. You can also listen on Spotify, Apple Podcasts, Stitcher, Pocket Casts or wherever you […]
Read moreFeds to Nix Work Requirements in Montana Medicaid Expansion Program
Federal health officials will likely reject Montana’s request to include work requirements for beneficiaries of its Medicaid expansion program, which insures 100,000 low-income Montana adults, […]
Read moreFDA Approves Bristol Myers Squibb’s Zeposia (ozanimod), an Oral Treatment for Adults with Moderately to Severely Active Ulcerative Colitis
PRINCETON, N.J.–(BUSINESS WIRE) May 27, 2021 — Bristol Myers Squibb (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Zeposia (ozanimod) 0.92 […]
Read more